See more : M3-Brigade Acquisition III Corp. (MBSC-UN) Income Statement Analysis – Financial Results
Complete financial analysis of BrightSpring Health Services, Inc. Common Stock (BTSG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BrightSpring Health Services, Inc. Common Stock, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Shanghai Feilo Acoustics Co.,Ltd (600651.SS) Income Statement Analysis – Financial Results
- Shanghai Prisemi Electronics Co.,Ltd. (688230.SS) Income Statement Analysis – Financial Results
- Mondi plc (MONDF) Income Statement Analysis – Financial Results
- Silver Tiger Metals Inc. (SLVR.V) Income Statement Analysis – Financial Results
- Goldenstone Acquisition Limited (GDSTU) Income Statement Analysis – Financial Results
BrightSpring Health Services, Inc. Common Stock (BTSG)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.brightspringhealth.com
About BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 8.83B | 7.72B | 6.70B | 5.58B | 4.53B | 2.54B |
Cost of Revenue | 7.39B | 6.37B | 5.45B | 4.53B | 3.69B | 2.16B |
Gross Profit | 1.43B | 1.35B | 1.25B | 1.05B | 833.91M | 375.91M |
Gross Profit Ratio | 16.24% | 17.54% | 18.64% | 18.79% | 18.43% | 14.82% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.29B | 1.06B | 1.01B | 774.93M | 696.36M | 301.06M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 1.29B | 1.06B | 1.01B | 774.93M | 696.36M | 301.06M |
Cost & Expenses | 8.68B | 7.42B | 6.46B | 5.31B | 4.39B | 2.46B |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 324.59M | 233.58M | 165.32M | 138.95M | 166.89M | 74.61M |
Depreciation & Amortization | 202.34M | 203.97M | 199.16M | 181.50M | 154.87M | 81.17M |
EBITDA | 349.52M | 500.00M | 433.34M | 346.69M | 292.41M | 156.02M |
EBITDA Ratio | 3.96% | 6.48% | 6.47% | 8.16% | 6.46% | 6.15% |
Operating Income | 147.18M | 296.03M | 234.18M | 273.81M | 137.55M | 74.85M |
Operating Income Ratio | 1.67% | 3.83% | 3.50% | 4.91% | 3.04% | 2.95% |
Total Other Income/Expenses | -324.59M | -341.78M | -165.32M | -138.95M | -241.13M | -85.68M |
Income Before Tax | -177.41M | -45.75M | 68.86M | 26.24M | -103.58M | -10.83M |
Income Before Tax Ratio | -2.01% | -0.59% | 1.03% | 0.47% | -2.29% | -0.43% |
Income Tax Expense | -20.58M | 8.47M | 17.60M | 5.09M | -32.49M | -3.21M |
Net Income | -154.60M | -53.91M | 49.80M | 20.81M | -72.38M | -7.62M |
Net Income Ratio | -1.75% | -0.70% | 0.74% | 0.37% | -1.60% | -0.30% |
EPS | -0.90 | -0.31 | 0.29 | 2.79 | -10.26 | -1.57 |
EPS Diluted | -0.90 | -0.31 | 0.29 | 2.78 | -10.26 | -1.57 |
Weighted Avg Shares Out | 171.19M | 171.19M | 171.19M | 7.45M | 7.06M | 4.85M |
Weighted Avg Shares Out (Dil) | 171.19M | 171.19M | 171.19M | 7.49M | 7.06M | 4.85M |
BrightSpring Health Services Announces Onco360® Has Been Selected as a Partner for Several New Drugs
BrightSpring Health Services, Inc. to Participate in Two Upcoming Investor Conferences
BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®
BrightSpring Health Services, Inc. (BTSG) Q3 2024 Earnings Call Transcript
BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
Global IPO Activity Picking Up But Continues To Lag Other Post-COVID Years
FMR LLC's Strategic Acquisition in BrightSpring Health Services Inc
BrightSpring Health Services, Inc. to Announce Third Quarter 2024 Financial Results on November 1, 2024
BrightSpring Health Services, Inc. Welcomes Dr. Steve Miller to Board of Directors
Levi & Korsinsky Investigates Possible Securities Fraud Violations by BrightSpring Health Services, Inc. (BTSG)
Source: https://incomestatements.info
Category: Stock Reports